Search - tctmd.com

Displaying 121 - 140 of 409

Sort: Relevancy | Date

News Daily News

Autism and Cardiometabolic Disease Often Go Hand in Hand

Caitlin E. Cox

February 06, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2023

Caitlin E. Cox

February 01, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

Vegan Soul Food Study Raises Interesting Questions About ‘Healthy’ Diets

L.A. McKeown

January 18, 2023

News Daily News

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Yael L. Maxwell

January 17, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men

Michael O'Riordan

January 10, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Daily News

A Simple Nudge Moves the Needle on Statin Prescribing

Michael O'Riordan

December 02, 2022

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

News Daily News

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Caitlin E. Cox

August 31, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

Advertisement

Autism and Cardiometabolic Disease Often Go Hand in Hand

TCTMD’s Top 10 Most Popular Stories for January 2023

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Vegan Soul Food Study Raises Interesting Questions About ‘Healthy’ Diets

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Top General Cardiology and Prevention News of 2022

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

A Simple Nudge Moves the Needle on Statin Prescribing

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content